Final results of the EORTC Brain Tumor Group randomized phase II TAVAREC trial on temozolomide with or without bevacizumab in 1st recurrence grade II/III glioma without 1p/19q co-deletion.

Martin J. Van Den Bent; Martin Klein; Marion Smits; Jaap C. Reijneveld; Ahmed Idbaih; Paul Clement; Filip Yves Francine Leon De Vos; Wolfgang Wick; Paul James Mulholland; Martin J. B. Taphoorn; Joanne Lewis; Iris de Heer; Johan M. Kros; Tina Verschuere; Vassilis Golfinopoulos; Thierry Gorlia; Pim French

doi:https://doi.org/10.1200/JCO.2017.35.15_suppl.2009

Final results of the EORTC Brain Tumor Group randomized phase II TAVAREC trial on temozolomide with or without bevacizumab in 1st recurrence grade II/III glioma without 1p/19q co-deletion.

Martin J. Van Den Bent, Martin Klein, Marion Smits, Jaap C. Reijneveld, Ahmed Idbaih, Paul Clement, Filip Yves Francine Leon De Vos, Wolfgang Wick, Paul James Mulholland, Martin J. B. Taphoorn, Joanne Lewis, Iris de Heer, Johan M. Kros, Tina Verschuere, Vassilis Golfinopoulos, Thierry Gorlia, Pim French

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Journal	Journal of clinical oncology
Volume	35
DOIs	https://doi.org/10.1200/JCO.2017.35.15_suppl.2009
Publication status	Published - 20 May 2017

Access to Document

https://doi.org/10.1200/JCO.2017.35.15_suppl.2009

Cite this

Van Den Bent, M. J., Klein, M., Smits, M., Reijneveld, J. C., Idbaih, A., Clement, P., De Vos, F. Y. F. L., Wick, W., Mulholland, P. J., Taphoorn, M. J. B., Lewis, J., de Heer, I., Kros, J. M., Verschuere, T., Golfinopoulos, V., Gorlia, T., & French, P. (2017). Final results of the EORTC Brain Tumor Group randomized phase II TAVAREC trial on temozolomide with or without bevacizumab in 1st recurrence grade II/III glioma without 1p/19q co-deletion. Journal of clinical oncology, 35. https://doi.org/10.1200/JCO.2017.35.15_suppl.2009

@article{fdc4aa413a314a2f95c6a18ca6509c0c,

title = "Final results of the EORTC Brain Tumor Group randomized phase II TAVAREC trial on temozolomide with or without bevacizumab in 1st recurrence grade II/III glioma without 1p/19q co-deletion.",

author = "{Van Den Bent}, {Martin J.} and Martin Klein and Marion Smits and Reijneveld, {Jaap C.} and Ahmed Idbaih and Paul Clement and {De Vos}, {Filip Yves Francine Leon} and Wolfgang Wick and Mulholland, {Paul James} and Taphoorn, {Martin J. B.} and Joanne Lewis and {de Heer}, Iris and Kros, {Johan M.} and Tina Verschuere and Vassilis Golfinopoulos and Thierry Gorlia and Pim French",

year = "2017",

month = may,

day = "20",

doi = "https://doi.org/10.1200/JCO.2017.35.15_suppl.2009",

language = "English",

volume = "35",

journal = "Journal of clinical oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

}

Van Den Bent, MJ, Klein, M, Smits, M, Reijneveld, JC, Idbaih, A, Clement, P, De Vos, FYFL, Wick, W, Mulholland, PJ, Taphoorn, MJB, Lewis, J, de Heer, I, Kros, JM, Verschuere, T, Golfinopoulos, V, Gorlia, T & French, P 2017, 'Final results of the EORTC Brain Tumor Group randomized phase II TAVAREC trial on temozolomide with or without bevacizumab in 1st recurrence grade II/III glioma without 1p/19q co-deletion.', Journal of clinical oncology, vol. 35. https://doi.org/10.1200/JCO.2017.35.15_suppl.2009

Final results of the EORTC Brain Tumor Group randomized phase II TAVAREC trial on temozolomide with or without bevacizumab in 1st recurrence grade II/III glioma without 1p/19q co-deletion. / Van Den Bent, Martin J.; Klein, Martin; Smits, Marion et al.
In: Journal of clinical oncology, Vol. 35, 20.05.2017.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - Final results of the EORTC Brain Tumor Group randomized phase II TAVAREC trial on temozolomide with or without bevacizumab in 1st recurrence grade II/III glioma without 1p/19q co-deletion.

AU - Van Den Bent, Martin J.

AU - Klein, Martin

AU - Smits, Marion

AU - Reijneveld, Jaap C.

AU - Idbaih, Ahmed

AU - Clement, Paul

AU - De Vos, Filip Yves Francine Leon

AU - Wick, Wolfgang

AU - Mulholland, Paul James

AU - Taphoorn, Martin J. B.

AU - Lewis, Joanne

AU - de Heer, Iris

AU - Kros, Johan M.

AU - Verschuere, Tina

AU - Golfinopoulos, Vassilis

AU - Gorlia, Thierry

AU - French, Pim

PY - 2017/5/20

Y1 - 2017/5/20

U2 - https://doi.org/10.1200/JCO.2017.35.15_suppl.2009

DO - https://doi.org/10.1200/JCO.2017.35.15_suppl.2009

M3 - Meeting Abstract

SN - 0732-183X

VL - 35

JO - Journal of clinical oncology

JF - Journal of clinical oncology

ER -